Canada · Delayed Price · Currency is CAD Kits Eyecare Statistics
Total Valuation
Kits Eyecare has a market cap or net worth of CAD 520.98 million. The enterprise value is 498.74 million.
| Market Cap | 520.98M |
| Enterprise Value | 498.74M |
Important Dates
The next estimated earnings date is Wednesday, November 4, 2026.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Kits Eyecare has 34.01 million shares outstanding. The number of shares has increased by 0.36% in one year.
| Current Share Class | 34.01M |
| Shares Outstanding | 34.01M |
| Shares Change (YoY) | +0.36% |
| Shares Change (QoQ) | +0.78% |
| Owned by Insiders (%) | 26.51% |
| Owned by Institutions (%) | 15.17% |
| Float | 14.49M |
Valuation Ratios
The trailing PE ratio is 95.69 and the forward PE ratio is 59.77.
| PE Ratio | 95.69 |
| Forward PE | 59.77 |
| PS Ratio | 2.34 |
| PB Ratio | 7.16 |
| P/TBV Ratio | 16.81 |
| P/FCF Ratio | 49.05 |
| P/OCF Ratio | 42.79 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 46.52, with an EV/FCF ratio of 46.95.
| EV / Earnings | 88.55 |
| EV / Sales | 2.24 |
| EV / EBITDA | 46.52 |
| EV / EBIT | 58.50 |
| EV / FCF | 46.95 |
Financial Position
The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.07.
| Current Ratio | 1.77 |
| Quick Ratio | 0.94 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.48 |
| Debt / FCF | 0.48 |
| Interest Coverage | 16.30 |
Financial Efficiency
Return on equity (ROE) is 8.54% and return on invested capital (ROIC) is 11.16%.
| Return on Equity (ROE) | 8.54% |
| Return on Assets (ROA) | 5.22% |
| Return on Invested Capital (ROIC) | 11.16% |
| Return on Capital Employed (ROCE) | 11.00% |
| Weighted Average Cost of Capital (WACC) | 5.80% |
| Revenue Per Employee | 1.26M |
| Profits Per Employee | 32,000 |
| Employee Count | 176 |
| Asset Turnover | 2.18 |
| Inventory Turnover | 6.08 |
Taxes
In the past 12 months, Kits Eyecare has paid 2.64 million in taxes.
| Income Tax | 2.64M |
| Effective Tax Rate | 31.87% |
Stock Price Statistics
The stock price has decreased by -1.03% in the last 52 weeks. The beta is 0.28, so Kits Eyecare's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -1.03% |
| 50-Day Moving Average | 14.60 |
| 200-Day Moving Average | 15.58 |
| Relative Strength Index (RSI) | 52.15 |
| Average Volume (20 Days) | 73,893 |
Short Selling Information
The latest short interest is 14,456, so 0.05% of the outstanding shares have been sold short.
| Short Interest | 14,456 |
| Short Previous Month | 16,245 |
| Short % of Shares Out | 0.05% |
| Short % of Float | 0.18% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Kits Eyecare had revenue of CAD 222.18 million and earned 5.63 million in profits. Earnings per share was 0.16.
| Revenue | 222.18M |
| Gross Profit | 82.66M |
| Operating Income | 8.53M |
| Pretax Income | 8.27M |
| Net Income | 5.63M |
| EBITDA | 9.70M |
| EBIT | 8.53M |
| Earnings Per Share (EPS) | 0.16 |
Balance Sheet
The company has 27.39 million in cash and 5.15 million in debt, with a net cash position of 22.23 million or 0.65 per share.
| Cash & Cash Equivalents | 27.39M |
| Total Debt | 5.15M |
| Net Cash | 22.23M |
| Net Cash Per Share | 0.65 |
| Equity (Book Value) | 72.80M |
| Book Value Per Share | 2.15 |
| Working Capital | 24.70M |
Cash Flow
In the last 12 months, operating cash flow was 12.18 million and capital expenditures -1.55 million, giving a free cash flow of 10.62 million.
| Operating Cash Flow | 12.18M |
| Capital Expenditures | -1.55M |
| Depreciation & Amortization | 1.17M |
| Net Borrowing | -3.82M |
| Free Cash Flow | 10.62M |
| FCF Per Share | 0.31 |
Margins
Gross margin is 37.21%, with operating and profit margins of 3.84% and 2.53%.
| Gross Margin | 37.21% |
| Operating Margin | 3.84% |
| Pretax Margin | 3.72% |
| Profit Margin | 2.53% |
| EBITDA Margin | 4.36% |
| EBIT Margin | 3.84% |
| FCF Margin | 4.78% |
Dividends & Yields
Kits Eyecare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.36% |
| Shareholder Yield | -0.36% |
| Earnings Yield | 1.08% |
| FCF Yield | 2.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Kits Eyecare is 22.93, which is 49.67% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 22.93 |
| Price Target Difference | 49.67% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 17.18% |
| EPS Growth Forecast (3Y) | 71.77% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Kits Eyecare has an Altman Z-Score of 10.72 and a Piotroski F-Score of 7.
| Altman Z-Score | 10.72 |
| Piotroski F-Score | 7 |